<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2226">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04376840</url>
  </required_header>
  <id_info>
    <org_study_id>PO20066</org_study_id>
    <nct_id>NCT04376840</nct_id>
  </id_info>
  <brief_title>Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia</brief_title>
  <official_title>Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Reims</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Studies performed after coronavirus epidemics (severe acute respiratory syndrome coronavirus,
      SARS-CoV and Middle East respiratory syndrome coronavirus, MERS-CoV) have shown a long-term
      impact on respiratory morbidity, musculoskeletal and psycho-social repercussions.

      Patients with SARS-CoV pneumonia had fibrotic pulmonary sequelae at 45 days (lower DLCO in
      27.3% of cases and radiological lesions in 21.5% of cases). In the MERS-CoV pneumonia study,
      patients had radiological sequelae in 33% of cases and the 12-month evaluation showed
      persistence of radiological abnormalities in 23.7% of the cases despite an improvement in
      respiratory function.

      Clinical presentation and therapeutic management of severe SARS-CoV-2 infection are in part
      similar to those induced by SARS-CoV and MERS-CoV. Long-term respiratory complications are
      therefore expected.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective is to evaluate prevalence of long-term respiratory complications after severe
      SARS-CoV2 pneumonia.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 15, 2020</start_date>
  <completion_date type="Anticipated">October 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>medium-term respiratory complications</measure>
    <time_frame>3 months</time_frame>
    <description>Interstitial lung disease diagnosed with a thoracic CT-scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>long-term respiratory complications</measure>
    <time_frame>12 months</time_frame>
    <description>Interstitial lung disease diagnosed with a thoracic CT-scan</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Severe SARS-CoV2 Pneumonia</condition>
  <arm_group>
    <arm_group_label>adults with severe SARS-CoV2 pneumonia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>adult with severe SARS-CoV2 pneumonia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sample and data record</intervention_name>
    <description>Blood sample and data record</description>
    <arm_group_label>adults with severe SARS-CoV2 pneumonia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient

          -  Patient with with severe SARS-CoV2 pneumonia

          -  Patient consenting to participate to the study

          -  Patient enrolled in the national healthcare insurance program

        Exclusion Criteria:

          -  Patient under 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jeanne-Marie PEROTIN-COLLARD</last_name>
    <phone>03 10 73 67 63</phone>
    <email>jmperotin-collard@chu-reims.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Damien JOLLY</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Jeanne-Marie PEROTIN-COLLARD</last_name>
      <phone>03 10 73 67 63</phone>
      <phone_ext>0033</phone_ext>
      <email>jmperotin-collard@chu-reims.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2020</study_first_posted>
  <last_update_submitted>May 5, 2020</last_update_submitted>
  <last_update_submitted_qc>May 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SARS-CoV2</keyword>
  <keyword>long term</keyword>
  <keyword>complication</keyword>
  <keyword>pneumonia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

